William Wan

2.0k total citations · 1 hit paper
23 papers, 1.5k citations indexed

About

William Wan is a scholar working on Epidemiology, Genetics and Biomedical Engineering. According to data from OpenAlex, William Wan has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Genetics and 7 papers in Biomedical Engineering. Recurrent topics in William Wan's work include Herpesvirus Infections and Treatments (9 papers), Cytomegalovirus and herpesvirus research (7 papers) and Elasticity and Material Modeling (6 papers). William Wan is often cited by papers focused on Herpesvirus Infections and Treatments (9 papers), Cytomegalovirus and herpesvirus research (7 papers) and Elasticity and Material Modeling (6 papers). William Wan collaborates with scholars based in United States, China and Belarus. William Wan's co-authors include James R. Beadle, Karl Y. Hostetler, Earl R. Kern, Rudolph L. Gleason, Caroll B. Hartline, Debra C. Quenelle, Deborah J. Collins, Eric M. Green, Johan D. Oslob and Marc Evanchik and has published in prestigious journals such as Science, Biophysical Journal and Journal of Medicinal Chemistry.

In The Last Decade

William Wan

21 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice

2016 467 citations Eric M. Green, Hiroko Wakimoto et al. Science profile →

Peers

William Wan

EPIDE

CCM

GENET

Xianfang Wu United States

Daniel P. Bednarik United States

Simon D. Scott United Kingdom

Sylvain Fleury Switzerland

Waldemar Popik United States

Gert Grauls Netherlands

Takeshi Sato Japan

Peter Lischka Germany

Rebecca C. Furze United Kingdom

Sean N. Tucker United States

Xianfang Wu United States

William Wan

551 ×0.8

EPIDE

191 ×0.4

CCM

972 ×2.6

118 ×0.4

GENET

390 ×1.4

Citations per year, relative to William Wan William Wan (= 1×) peers Xianfang Wu

Countries citing papers authored by William Wan

Since Specialization

Citations

This map shows the geographic impact of William Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Wan more than expected).

Fields of papers citing papers by William Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Wan. The network helps show where William Wan may publish in the future.

Co-authorship network of co-authors of William Wan

This figure shows the co-authorship network connecting the top 25 collaborators of William Wan. A scholar is included among the top collaborators of William Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Wan. William Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Weiyang, Zhipeng Dong, Jiajing Wu, et al.. (2025). Efficient airborne transmission of influenza D virus in ferret models and serological evidence of human exposure in Northeast China. Emerging Microbes & Infections. 14(1). 2564308–2564308.

Green, Eric M., Hiroko Wakimoto, Robert L. Anderson, et al.. (2016). A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science. 351(6273). 617–621. 467 indexed citations breakdown →

Wan, William, J. Brandon Dixon, & Rudolph L. Gleason. (2012). Constitutive Modeling of Mouse Carotid Arteries Using Experimentally Measured Microstructural Parameters. Biophysical Journal. 102(12). 2916–2925. 51 indexed citations

Wan, William & Rudolph L. Gleason. (2012). Dysfunction in elastic fiber formation in fibulin-5 null mice abrogates the evolution in mechanical response of carotid arteries during maturation. American Journal of Physiology-Heart and Circulatory Physiology. 304(5). H674–H686. 22 indexed citations

Weiss, Daiana, et al.. (2011). Catalase overexpression in aortic smooth muscle prevents pathological mechanical changes underlying abdominal aortic aneurysm formation. American Journal of Physiology-Heart and Circulatory Physiology. 301(2). H355–H362. 44 indexed citations

Wan, William, Hiromi Yanagisawa, & Rudolph L. Gleason. (2010). Biomechanical and Microstructural Properties of Common Carotid Arteries from Fibulin-5 Null Mice. Annals of Biomedical Engineering. 38(12). 3605–3617. 62 indexed citations

Raykin, Julia, William Wan, Robert Gauvin, et al.. (2009). A Novel Cylindrical Biaxial Computer-Controlled Bioreactor and Biomechanical Testing Device for Vascular Tissue Engineering. Tissue Engineering Part A. 15(11). 3331–3340. 27 indexed citations

Wan, William, Laura Hansen, & Rudolph L. Gleason. (2009). A 3-D constrained mixture model for mechanically mediated vascular growth and remodeling. Biomechanics and Modeling in Mechanobiology. 9(4). 403–419. 26 indexed citations

Hansen, Laura, William Wan, & Rudolph L. Gleason. (2009). Microstructurally Motivated Constitutive Modeling of Mouse Arteries Cultured Under Altered Axial Stretch. Journal of Biomechanical Engineering. 131(10). 101015–101015. 22 indexed citations

10.

Quenelle, Debra C., Deborah J. Collins, Caroll B. Hartline, et al.. (2008). Effect of oral treatment with (S)-HPMPA, HDP-(S)-HPMPA or ODE-(S)-HPMPA on replication of murine cytomegalovirus (MCMV) or human cytomegalovirus (HCMV) in animal models. Antiviral Research. 79(2). 133–135. 14 indexed citations

11.

Gleason, Rudolph L. & William Wan. (2008). Theory and Experiments for Mechanically-Induced Remodeling of Tissue Engineered Blood Vessels. Advances in science and technology. 57. 226–234. 2 indexed citations

12.

Beadle, James R., William Wan, Kathy A. Keith, et al.. (2006). Synthesis and Antiviral Evaluation of Alkoxyalkyl Derivatives of 9-(S)-(3-Hydroxy-2-phosphonomethoxypropyl)adenine against Cytomegalovirus and Orthopoxviruses. Journal of Medicinal Chemistry. 49(6). 2010–2015. 57 indexed citations

13.

Hartline, Caroll B., Kortney M. Gustin, William Wan, et al.. (2005). Ether Lipid‐Ester Prodrugs of Acyclic Nucleoside Phosphonates: Activity against Adenovirus Replication In Vitro. The Journal of Infectious Diseases. 191(3). 396–399. 101 indexed citations

14.

Hartline, Caroll B., Emma A. Harden, Shannon L. Daily, et al.. (2005). Comparative Activities of Lipid Esters of Cidofovir and Cyclic Cidofovir against Replication of Herpesviruses In Vitro. Antimicrobial Agents and Chemotherapy. 49(9). 3724–3733. 106 indexed citations

15.

Wan, William, James R. Beadle, Caroll B. Hartline, et al.. (2005). Comparison of the Antiviral Activities of Alkoxyalkyl and Alkyl Esters of Cidofovir against Human and Murine Cytomegalovirus Replication In Vitro. Antimicrobial Agents and Chemotherapy. 49(2). 656–662. 61 indexed citations

16.

Bidanset, Deborah J., James R. Beadle, William Wan, Karl Y. Hostetler, & Earl R. Kern. (2004). Oral Activity of Ether Lipid Ester Prodrugs of Cidofovir against Experimental Human Cytomegalovirus Infection. The Journal of Infectious Diseases. 190(3). 499–503. 67 indexed citations

17.

Quenelle, Debra C., Deborah J. Collins, William Wan, et al.. (2004). Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of Cidofovir. Antimicrobial Agents and Chemotherapy. 48(2). 404–412. 119 indexed citations

18.

Kern, Earl R., Deborah J. Collins, William Wan, et al.. (2004). Oral Treatment of Murine Cytomegalovirus Infections with Ether Lipid Esters of Cidofovir. Antimicrobial Agents and Chemotherapy. 48(9). 3516–3522. 57 indexed citations

19.

Keith, Kathy A., et al.. (2004). Inhibitory Activity of Alkoxyalkyl and Alkyl Esters of Cidofovir and Cyclic Cidofovir against Orthopoxvirus Replication In Vitro. Antimicrobial Agents and Chemotherapy. 48(5). 1869–1871. 52 indexed citations

20.

Wan, William, et al.. (2003). Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney. Antiviral Research. 59(3). 163–171. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact